Kim, J.H.; Kim, E.T.; Kim, S.I.; Park, E.Y.; Park, M.Y.; Park, S.-Y.; Lim, M.C.
Prognostic Role of CA-125 Elimination Rate Constant (KELIM) in Patients with Advanced Epithelial Ovarian Cancer Who Received PARP Inhibitors. Cancers 2024, 16, 2339.
https://doi.org/10.3390/cancers16132339
AMA Style
Kim JH, Kim ET, Kim SI, Park EY, Park MY, Park S-Y, Lim MC.
Prognostic Role of CA-125 Elimination Rate Constant (KELIM) in Patients with Advanced Epithelial Ovarian Cancer Who Received PARP Inhibitors. Cancers. 2024; 16(13):2339.
https://doi.org/10.3390/cancers16132339
Chicago/Turabian Style
Kim, Ji Hyun, Eun Taeg Kim, Se Ik Kim, Eun Young Park, Min Young Park, Sang-Yoon Park, and Myong Cheol Lim.
2024. "Prognostic Role of CA-125 Elimination Rate Constant (KELIM) in Patients with Advanced Epithelial Ovarian Cancer Who Received PARP Inhibitors" Cancers 16, no. 13: 2339.
https://doi.org/10.3390/cancers16132339
APA Style
Kim, J. H., Kim, E. T., Kim, S. I., Park, E. Y., Park, M. Y., Park, S. -Y., & Lim, M. C.
(2024). Prognostic Role of CA-125 Elimination Rate Constant (KELIM) in Patients with Advanced Epithelial Ovarian Cancer Who Received PARP Inhibitors. Cancers, 16(13), 2339.
https://doi.org/10.3390/cancers16132339